Evaluation of micronucleated lymphocytes, constitutional karyotypes and anti-p53 antibodies in 21 children with various malignancies

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 467, Issue 1, 2000, Pages 31-39

  Fellay Reynier, I ^a   Orsiere T ^a   Sari Minodier, I ^a   Auquier, P ^a   Zattara Cannoni, H ^b   Capodano, A M ^b   Coze, C ^c   De Meo M ^a   Bernard, J L ^c   Botta, A ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Lab de Cytogenetique Oncologique   (France)

^c Hop Timone 264 R S Pierre 13005   (France)

Author keywords

Anti p53 antibodies; Cancer; Children; Human lymphocytes; Micronuclei

Indexed keywords

ANTIBODY; CARCINOGEN; ENVIRONMENTAL CHEMICAL; PROTEIN ANTIBODY; PROTEIN P53;

ADOLESCENT; ARTICLE; CHILDHOOD CANCER; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INFANT; KARYOTYPE; LYMPHOCYTE; MALE; MICRONUCLEUS; MICRONUCLEUS TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ANTIBODIES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; KARYOTYPING; LYMPHOCYTES; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0343570148     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(00)00023-1     Document Type: Article

References (43)

1. Karahalil B., Burgaz S., Fisek G., Karakaya A.E. Biological monitoring of young workers exposed to polycyclic aromatic hydrocarbons in engine repair workshops. Mutat. Res. 412:1998;261-269.
2. L.A.G. Ries, C.L. Koary, B.F. Hankey, B.A. Miller, A. Harras, B. Edwards, SEER Cancer Statistics Review, 1973-1994, NIH Publ. 97-2789, National Cancer Institute, Bethesda, MD, 1997.
3. Gurney J.G., Davis S., Severson R.K., Fang J.Y., Ross J.A., Robinson L.L. Trends in cancer incidence among children in the US. Cancer. 78:1996;532-541.
4. Kaatsh G., Haaf J. Childhood malignancies in Germany methods and results of a nationwide registry. Eur. J. Cancer. 31:1995;993-999.
5. Blair V., Birch J.M. Patterns and temporal trends in the incidence of malignant disease in children: I. Leukemia and lymphoma. Eur. J. Cancer. 30:1994;1490-1498.
6. Blair V., Birch J.M. Patterns and temporal trends in the incidence of malignant disease in children: II. Solid tumour of childhood. Eur. J. Cancer. 30:1994;1498-1511.
7. Linet M.S., Ries L.A., Smith M.A., Tarone R.E., Devesa S.S. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J. Natl. Cancer Inst. 91:1999;1051-1058.
8. Colt J.S., Blair A. Parental occupational exposures and risk of childhood cancer. Environ. Health Perspect. 106:1998;909-925.
9. Bearer C.F. Biomarkers in pediatric environmental health: a cross cutting issue. Environ. Health Perspect. 106:1998;813-816.
10. Thorkild I., Sorensen A. Is there an inherited general susceptibility to cancer? N. Engl. J. Med. 333:1995;1633-1635.
11. Wiencke J., Wrensch M.R., Miike R., Petrakis N.L. Individual susceptibility to induce chromosome damage and its implication for detecting genotoxic exposures in human populations. Cancer Res. 51:1991;5266-5269.
12. Duffaud F., Orsière T., Digue L., Villani P., Volot F., Favre R., Botta A. Micronucleated lymphocyte rates from head-and-neck cancer patients. Mutat. Res. 439:1999;259-266.
13. Fenech M. The cytokinesis block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human population. Mutat. Res. 285:1993;35-44.
14. Donovan O. Meeting report: the industrial genetic toxicology discussion group meeting on in vivo micronucleus tests. Mutagenesis. 5:1990;417-418.
15. Dulout F.N., Grillo C.A., Seoanne A.I., Maderna C.R., Nilsson R., Vahter M., Darroudi F., Natarajan A.T. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from Northwestern Argentina exposed to arsenic in drinking water. Mutat. Res. 370:1996;151-158.
16. Lane D.P. P53 and human cancers. Br. Med. Bull. 50:1994;582-599.
17. Caron de Fromentel C., May-Levin F., Mouriesse H., Lemerle J., Chandrasekaran K., May P. Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma. Int. J. Cancer. 39:1987;185-189.
18. Kusafuka T., Fukuzawa M., Oue T., Komoto Y., Yoneda A., Okada A. Mutation analysis of p53 gene in childhood malignant solid tumors. J. Pediatr. Surg. 32:1997;1175-1180.
19. Diamandis P. Clinical applications of the p53 tumor suppressor gene. Clin. Chim. Acta. 237:1995;79-90.
20. Bokemeyer C., Kuczyk M.A., Sehrt J. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 330:1994;865.
21. Ryberg D., Kure E., Lystad S., Skang V., Stangeland L., Mercy I., Borresen A.L., Hangen A. P53 mutations in lung tumors: relationship to putative susceptibility markers for carcinoma. Cancer Res. 54:1994;1551-1555.
22. Dutrillaux B., Lejeune J. Une nouvelle technique pour l'analyse des caryotypes humains. C. R. Acad. Sci. 272:1971;2638-2640.
23. An international system for human cytogenetic nomenclature. Cytogenet. Cell Genet. 21:1978;309-404.
24. Vleminckx C., Klemans W., Schriewer L., Joris I., Lijsen N., Ottogali M., Pays A., Planard C., Rigaux G., Ros Y., Vande Rivière M., Vandevelde J., De Plaen P., Lakhanisky Th., Maes A., Verschaeve L. Performance of cytogenetic biomarkers on children exposed to environmental pollutants. Toxicol. Ind. Health. 13:1997;219-230.
25. Migliore L., Guidotti P., Favre C., Nardi M., Sessa M.R., Brunori E. Micronuclei in lymphocytes of young patients under antileukemic therapy. Mutat. Res. 263:1991;243-248.
26. Duffaud F., Orsière T., Villani P., Pelissier A.L., Volot F., Favre R., Botta A. Comparison between micronucleated lymphocyte rates observed in healthy subjects and cancer patients. Mutagenesis. 12:1997;227-231.
27. D'Errico M., Calcagnile A., Iavarone I., Sera F., Baliva G., Chinni LM., Corona R., Pasquini P., Dogliotti E. Factors that influence the DNA repair capacity of normal and skin cancer-affected individuals. Cancer Epidemiol. Biomarkers Prev. 8:1999;553-559.
28. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc. Natl. Acad. Sci. U.S.A. 90(4):1993;1614-1618.
29. Moriwaki SI., Ray S., Tarone R.E., Kraemer K.H., Grossman L. The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat. Res. 364:1996;117-123.
30. Zotta-Martelli L., Migliore L., Panasiuk G., Barale R. Micronucleus frequency in Gomel (Belarus) children affected and not affected by thyroïd cancer. Mutat. Res. 440:1999;35-43.
31. Bolognesi C., Abbondandolo A., Barale R., Casalone R., Dalpra L., De Ferrari M., Degrassi F., Forno A., Lamberti L., Lando C., Migliore L., Padovani P., Pasquini R., Puntoni R., Sbrana I., Stella M., Bonassi S. Age related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes. Cancer Epidemiol. Biomarkers Prev. 6:1997;249-256.
32. Barale R., Chelotti L., Davini T., Del Ry S., Andreassi M.G., Ballardin M., Bulleri M., He J., Baldacci S., Di Pede F., Gemignani F., Landi S. Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1650 subjects in an Italian population: II Contribution of sex, age, and lifestyle. Environ. Mol. Mutagen. 31:1998;228-242.
33. Fenech M., Morley A. Measurement of micronuclei in lymphocytes. Mutat. Res. 147:1985;29-36.
34. Lee T.K., O'Brien K., Christie K., Wiley A.L. Jr., Karlsson U.L. Effect of ex vivo hyperthermia on radiation induced micronuclei in lymphocytes of cancer patients before and during radiotherapy. Mutat. Res. 417:1998;1-8.
35. Hoar Zahm S., Ward M.H. Pesticides and childhood cancer. Environ. Health. Perspect. 106:1998;893-908.
36. M.L. McBride, Childhood cancer and environmental contaminants, Can. J. Public Health 89 (1998) S53-62, S58-68.
37. Ron E., Lubin J.H., Shore R.E., Mabuchi K., Modan B., Pottern L.M., Schneider A.B., Tucker M.A., Boice J.D. Jr. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res. 141:1995;259-277.
38. Cahen F., Dubreuil E., Pons JC. Prenatal exposure to diethylstilbestrol and the mother-daughter relationship. Eur. J. Obstet. Gynecol. Reprod. Biol. 65:1996;181-187.
39. Draper G.J., Sanders B.M., Lennox E.L., Brownbill P.A. Patterns of childhood cancer among siblings. Br. J. Cancer. 74:1998;152-158.
40. Ramalho A.T., Sunjevaric I., Natarajan A.T. Use of the frequencies of micronuclei as quantitative indicators of X-ray-induced chromosomal aberrations in human peripheral blood lymphocytes: comparison of two methods. Mutat. Res. 207:1988;141-146.
41. A Nordic data base on somatic chromosome damage in humans. Mutat. Res. 241:1990;325-337.
42. Bonassi S., Abbondandolo A., Camurri L., Dal Prà L., De Ferrari M., Degrassi F., Forni A., Lamberti L., Lando C., Padovani P., Sbrana I., Vecchio D., Puntoni R. Are chromosome aberations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet. 79:1995;133-135.
43. Anderson D., Hughes J.A., Nizankowska E., Graca B., Cebulska-Wasilewska A., Kasper E. Factors affecting various biomarkers in untreated lung cancer patients and healthy donors. Environ. Mol. Mutagen. 30:1997;205-216.